MedBlue Incubator, Inc

MedBlue Incubator was founded in 2013 by the departments of Surgery, Pathology, Anesthesiology, Medicine, Neurosurgery, and Orthopedics at Duke University. It operates as a for-profit C corporation and is based at Duke University Medical Center. The organization focuses on identifying promising new science and technology from Duke University and assisting in their development into commercially viable businesses.

MedBlue Incubator provides seed funding and early-stage business support to entrepreneurs and companies emerging from Duke University. It aims to facilitate the commercialization of innovations and technologies with potential for significant impact on human health. The organization collaborates closely with the Duke University Office of Translation & Commercialization (OTC) to identify and advance promising ideas and intellectual property.

MedBlue Incubator offers seed funding of up to $75,000, early-stage business planning, IP-license negotiation support, IP-protection strategy, deal negotiation support, corporate partnership opportunities, regulatory pathway strategy, and general management guidance.

Q: What is the application process? A: Applications are reviewed by the Technology Review Committee, which selects promising medical technology opportunities for support. Q: When is the next application period? A: The application period opens on May 1, 2026, and closes on June 1, 2026.